Amgen has launched a late-stage program to test the feasibility of switching patients from weekly GLP-1 injections to its own investigational obesity asset MariTide, which could open up monthly or more infrequent dosing schedules.
The IRS and the Treasury posted temporary regulations and a notice of proposed rulemaking outlining a new way to recover federal excise taxes paid on dyed fuel.
The International Financial Reporting Standards Foundation revised its Due Process Handbook, outlining the steps used for developing IASB and ISSB standards.